Ultrasonic resonator technology as a new quality control method evaluating gelatin nanoparticles

Journal of Microencapsulation

Volumn 27, Issue 3, 2010, Pages 242-252

  Fuchs, Sebastian ^a   Winter, Gerhard ^a   Coester, Conrad ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Drug delivery; Formulation development; Gelatin nanoparticles; Quality assurance; Ultrasonic resonator technology

Indexed keywords

GELATIN; NANOPARTICLE; OLIGODEOXYNUCLEOTIDE;

ARTICLE; DRUG FORMULATION; NANOENCAPSULATION; NANOMEDICINE; PHOTON CORRELATION SPECTROSCOPY; QUALITY CONTROL; ULTRASONIC RESONATOR TECHNOLOGY; ULTRASOUND;

GELATIN; NANOPARTICLES; OLIGODEOXYRIBONUCLEOTIDES; PARTICLE SIZE; QUALITY CONTROL; ULTRASONICS;

EID: 77951488598     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652040903079534     Document Type: Article

References (45)

1. Archakov AI, Ivanov Y. 2007. Analytical nanobiotechnology for medicine diagnostics. Molec BioSyst 3:336-342.
2. Bivas-Benita M, Laloup M, Versteyhe S, Dewit J, De Braekeleer J, Jongert E, et al. 2003. Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: Preparation, characterization, and preliminary in vivo studies. Int J Pharm 266:17-27.
3. Bloomfield VA, Wilson RW, Rau DC. 1980. Polyelectrolyte effects in DNA condensation by polyamines. Biophys Chem 11:339-343.
4. Bourquin C, Schreiber S, Beck S, Endres S. 2006. Immunotherapy with dendritic cells and CpG oligonucleotides can be combined with chemotherapy without loss of efficacy in a mouse model of colon cancer. Int J Cancer 118:2790-2795.
5. Buckin V, O'Driscoll B, Smyth C, Alting AC, Visschers RW. 2003. Ultrasonic spectroscopy for material analysis. Recent advances. Spectroscopy Eur 15:20-25.
6. Buckin VA, Kankiya BI, Kazaryan RL. 1989. Hydration of nucleosides in dilute aqueous solutions. Ultrasonic velocity and density measurements. Biophys Chem 34:211-223.
7. Cetin M, Aktas Y, Vural I, Capan Y, Dogan LA, Duman M, et al. 2007. Preparation and in vitro evaluation of bFGF-loaded chitosan nanoparticles. Drug Deliv 14:525-529.
8. Chalikian TV, Plum GE, Sarvazyan AP, Breslaver KJ. 1994. Influence of drug binding on DNA hydration: Acoustic and densimetric characterizations of netropsin binding to the poly(dAdT).poly(dAdT) and poly(dA).poly(dT) duplexes and the poly(dT).poly(dA).poly(dT) triplex at 25C. Biochemistry 33:8629-8640.
9. Chavany C, Trung Le D, Couvreur P, Puisieux F, Helene C. 1992. Poly (alkyl cyanoacrylate) nanoparticles as polymeric carriers for antisense oligonucleotides. Pharm Res 9:441-449.
10. Coester C. 2003. Development of a new carrier system for oligonucleotides and plasmids based on gelatin nanoparticles. New Drugs (1):14-17.
11. Coester CJ, Langer K, Von Briesen H, Kreuter J. 2000. Gelatin nanoparticles by two step desolvation-a new preparation method, surface modifications and cell uptake. J Microencapsulation 17:187-193.
12. Eggers F. 1992. Ultrasonic velocity and attenuation measurements in liquids with resonators, extending the MHz frequency range. Acustica 76:231-240.
13. Fraley AW, Pons B, Dalkara D, Nullans G, Behr JP, Zuber G. 2006. Cationic oligonucleotide-peptide conjugates with aggregating properties enter efficiently into cells while maintaining hybridization properties and enzymatic recognition. J Am Chem Soc 128:10763-10771.
14. Fraunhofer W, Winter G, Coester C. 2004. Asymmetrical flow field-flow fractionation and multiangle light scattering for analysis of gelatin nanoparticle drug carrier systems. Anal Chem 76:1909-1920.
15. Funck T, De Maeyer L, Chalikian TV, Belonenko VN, Sarvazyan AP. 1993. A novel approach to the thermodynamic properties of fluid systems using acoustical measurements. Calor Anal Therm 24:139-142.
16. Gekko K. 2002. Compressibility gives new insight into protein dynamics and enzyme function. Biochim Biophys Acta 1595:382-386.
17. Gekko K, Noguchi H. 1979. Compressibility of globular proteins in water. J Phys Chem 83:2706-2714.
18. Giljohann DA, Seferos DS, Patel PC, Millstone JE, Rosi NL, Mirkin CA. 2007. Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles. Nano Lett 7:3818-3821.
19. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. 1994. Biodegradable long-circulating polymer nanospheres. Science 263:1600-1603.
20. Gu W, Xu Z, Gao Y, Chen L, Li Y. 2006. Transferrin-mediated PEGylated nanoparticles for delivery of DNA/PLL. Nanotechnology 17:4148-4155.
21. Gurusamy S, Park JH, Kim K, Kwon IC. 2007. Nanomedicine: An emerging modality based on nanotechnology for therapy and diagnosis. Kongop Hwahak 18:199-204.
22. Hoffmann F. 2006. Decoy gelatin nanoparticles as a novel tool to elucidate the role of NF-kB in Kupffer cells on hepatic ischemia/reperfusion injury. Dissertation, Munich.
23. Huang R, Yang W, Jiang C, Pei Y. 2006. Gene delivery into brain capillary endothelial cells using antp-modified DNA-loaded nanoparticles. Chem Pharm Bull 54:1254-1258.
24. Hurst SJ, Lytton J, Abigail KR, Mirkin CA. 2006. Maximizing DNA loading on a range of gold nanoparticle sizes. Anal. Chem 78 24: 8313-8318.
25. Jang JS, Kim SY, Lee SB, Kim KO, Han JS, Lee YM. 2006. Poly(ethylene glycol)/poly(e-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: The role of charge group and molecular weight in particle formation, cytotoxicity and transfection. J Contr Rel 113:173-182.
26. Kaul G, Amiji M. 2005a. Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles. J Pharm Sci 94:184-198.
27. Kaul G, Amiji M. 2005b. Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: In vitro and in vivo studies. Pharm Res 22:951-961.
28. Khan M, Shah R, Zidan A, Funck T, Tawakkul M. 2007. Quality by design: Characterisation of self-nano-emulsified drug delivery systems (SNEDDs) using ultrasonic resonator technology. Int J of Pharm 341:189-194.
29. Krieg AM. 2001. Immune stimulation by oligonucleotides. Antisense Drug Technol 471-515.
30. Krieg AM. 2002. Applications of CpG motifs from bacterial DNA in cancer immunotherapy. Cancer Immune Ther 268-286.
31. Negredo C, Monks E, Sweeney T. 2007. A novel real-time ultrasonic method for prion protein detection using plasminogen as a capture molecule. BMC Biotechnol 7:43.
32. Perez C, Sanchez A, Putnam D, Ting D, Langer R, Alonso MJ. 2001. Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. J Contr Rel 75:211-224.
33. Petri B, Bootz A, Khalansky A, Hekmatara T, Mueller R, Uhl R, et al. 2007. Chemotherapy of brain tumour using doxorubicin bound to surfactantcoated poly(butyl cyanoacrylate) nanoparticles: Revisiting the role of surfactants. J Contr Rel 117:51-58.
34. Pinfield VJ, Povey MJW. 1997. Thermal scattering must be accounted for in the determination of adiabatic compressibility. J Phys Chem B 101:1110-1112.
35. Roy I, Ohulchanskyy TY, Bharali DJ, Pudavar HE, Mistretta RA, Kaur N, et al. 2005. Optical tracking of organically modified silica nanoparticles as DNA carriers: A nonviral, nanomedicine approach for gene delivery. Proc Natl Acad Sci USA 102:279-284.
36. Sarvazyan AP. 1991. Ultrasonic velocimetry of biological compounds. Annu Rev Biophys Biophys Chem 20:321-342.
37. Shah RB, Zidan AS, Funck T, Tawakkul MA, Khan MA. 2007. Quality by design: Characterisation of self-nanp-emulsified drug delivery systems (SNEDDs) using ultrasonic resonator technology. Int J Pharm 341:189-194.
38. Sokolova V, Kovtun A, Prymak O, Meyer-Zaika W, Kubareva EA, Romanova EA, et al. 2007. Functionalization of calcium phosphate nanoparticles by oligonucleotides and their application for gene silencing. J Mater Chem 7:721-727.
39. Sparreboom A, Baker SD, Verweij J. 2005. Paclitaxel repackaged in an albumin-stabilized nanoparticle: Handy or just a dandy? J Clin Oncol 23:7765-7767.
40. Sun X, Duan YR, He Q, Lu J, Zhang ZR. 2005. PELGE nanoparticles as new carriers for the delivery of plasmid DNA. Chem Pharm Bull 53:599-603.
41. Tikhonov DA, Kiselyov OE, Sarvazyan AP, Sarkisov GN. 1995. Ultrasonic approach to obtaining partial thermodynamic characteristics of solutions. Ultrasonics 33:301-310.
42. Torchilin VP. 2007. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J 9:E128-E147.
43. Zillies J, Coester C. 2004. Evaluating gelatin based nanoparticles as a carrier system for double stranded oligonucleotides. J Pharm Pharm Sci 7:17-21. (Pubitemid 41522054)
44. Zillies J, Zwiorek K, Hoffmann F, Vollmar A, Anchordoquy T, Winter G, et al. 2008. Formulation development of freeze-dried oligonucleotideloaded gelatin nanoparticles. Eur J Pharm Biopharm 70 2:514-521.
45. Zwiorek K, Kloeckner J, Wagner E, Coester C. 2004. Gelatin nanoparticles as a new and simple gene delivery system. J Pharm Pharm Sci 7:22-28.